GostinLO. Public health law: power, duty, restraint. Berkeley (CA): University of California Press; 2001.
2.
GostinLO. Jacobson v. Massachusetts at 100 years: police power and civil liberties in tension. Am J Public Health2005;95:576–81.
3.
Chrysler Corp. v. Department of Transportation. 472 F.2d 659 (6th Cir. 1972).
4.
Motor Vehicle Manufacturer's Association of the U.S., Inc. v. State Farm Mutual Insurance Co. 463 U.S. 29 (1983).
5.
VernickJSMairJSTeretSPSapsinJW. Role of litigation in preventing product-related injuries. Epidemiol Rev2003;25:90–8.
6.
TeretSPJacobsM. Prevention and torts: the role of litigation in injury control. Law Med Health Care1989;17:17–22.
7.
VernickJSSapsinJWTeretSPMairJS. How litigation can promote product safety. J Law Med Ethics2004;32:551–5.
8.
TeretSP. Litigating for the public's health. Am J Public Health1986;76:1027–9.
9.
JacobsonPDSolimanS. Litigation as public health policy: theory or reality?J Law Med Ethics2002;30:224–38.
10.
SchroederSA. Tobacco control in the wake of the 1998 master settlement agreement. N Engl J Med2004;350:293–301.
11.
VernickJSRutkowLSalmonD. Availability of litigation as a tool for firearm injury prevention: comparing guns, vaccines, and motor vehicles. Am J Public Health2007;97:1991–7.
12.
MishraR. Rhode Island wins lead paint suit. The Boston Globe. 2006 Feb 23:Sect.B:2.
13.
Engle v. Liggett Group Inc., 945 So. 2d. 1246 (Fla. 2006).
14.
WinickBJ. Therapeutic jurisprudence and problem solving courts. Fordham Urban Law J2003;30:1055–90.
15.
PlattAM. The child savers: the invention of delinquency. 2nd ed.Chicago: University of Chicago; 1977.
16.
HoraPFSchmaWGRosenthalJTA. Therapeutic jurisprudence and the drug treatment court movement: revolutionizing the criminal justice system's response to drug abuse and crime in America. Notre Dame Law Rev1999;74:439–537.
17.
American University School of Public Affairs. BJA Drug Court Clearinghouse Project: summary of drug court activity by state and county. Washington: American University School of Public Affairs; 2009. Also available from: URL: http://spa.american.edu/justice/documents/2150.pdf [cited 2009 Mar 17].
18.
BelenkoS. Research on drug courts: a critical review, 2001 update. New York: Columbia University, National Center on Addiction and Substance Abuse; 2001.
19.
MarloweDBFestingerDSFoltzCLeePAPatapisNS. Perceived deterrence and outcomes in drug court. Behav Sci Law2005;23:183–98.
20.
EibnerCMorralARPaculaRLMacDonaldJ. Is the drug court model exportable? The cost-effectiveness of a driving-under-the-influence court. J Subst Abuse Treat2006;31:75–85.
21.
TsaiB. The trend toward specialized domestic violence courts: improvements on an effective innovation. Fordham Law Rev2000; 68:1285–327.
22.
National Drug Court Institute. DWI courts and DWI/drug courts: reducing recidivism, saving lives [cited 2009 Mar 17], Available from: URL: http://www.ndci.org/dwi_drug_court.htm
23.
MacDonaldJMMorralARRaymondBEibnerC. The efficacy of the Rio Hondo DUI Court: a 2-year field experiment. Eval Rev2007;31:4–23.
24.
Fed. R. Evid. 702.
25.
Daubert v. Merrell Dow Pharmaceuticals, Inc. 509 U.S. 579 (1993).
26.
HogeMATebesJ KraemerDavidsonLGriffithEEH. The roles of behavioral health professionals in class action litigation. J Am Acad Psychiatry Law2002;30:49–58.
27.
HammondCBSchwartzPA. Ethical issues related to medical expert testimony. Obstet Gynecol2005;106(5 Pt 1):1055–8.
28.
SametJM. Reflections: testifying in the Minnesota tobacco lawsuit. Tob Control1999;8:101–5.
29.
EatonDLKalmanD. Scientists in the courtroom: basic pointers for the expert scientific witness. Environ Health Perspect1994;102:668–72.
30.
VernickJSRutkowLTeretSP. Public health benefits of recent litigation against the tobacco industry. JAMA2007;298:86–9.
31.
EnnisBJ. Symposium on Supreme Court advocacy: effective amicus briefs. Catholic University Law Rev1984;33:603–9.
32.
Judicial Conference of the United States. Committee on Codes of Conduct Advisory Opinion No. 67. Washington: Administrative Office of the U.S. Courts; 1980 Aug 25 [revised 1998 Jul 10; revised 2004 Aug 16]. Also available from: URL: http://www.uscourts.gov/guide/vol2/67.html [cited 2009 Mar 17].
33.
KendallDTRylanderJC. Tainted justice: how private judicial trips undermine public confidence in the judiciary. Geo J Legal Ethics2004;18:65–134.
34.
KendallDTSorkinE. Nothing for free: how private judicial seminars are undermining environmental protections and breaking the public's trust. Harvard Environmental Law Rev2001;25:405–51.
35.
Judicial Conference of the United States. Judicial Conference policy on judges' attendance at privately funded educational programs. Washington: Administrative Office of the U.S. Courts; 2006 Sep 19. Also available from: URL: http://www.uscourts.gov/Press_Releases/judbrappc906c.pdf [cited 2009 Mar 17].
VernickJS. Lobbying and advocacy for the public's health: what are the limits for non-profit organizations?Am J Public Health1999;89:1425–9.
38.
FrattaroliSKuhnVTBishaiDMairJSGielenA. Evaluating MADD's Court Monitoring Program: informing advocacy through science: a mid-course progress report. Poster session presented at the Substance Abuse Policy Research Program Annual Grantee Meeting; 2005 Dec 15; Tucson, Arizona.
39.
ProbstJLewisJAsunkaKHerseyJOramS. Assessment of citizen group court monitoring programs. DOT HS 807 113. Washington: National Highway Traffic Safety Administration; 1987.
40.
ShinarD. Impact of court monitoring on the adjudication of driving while intoxicated (DWI). Accid Anal Prev1992;24:167–79.